Cash flow Akzo Nobel N.V.

Equities

AKZA

NL0013267909

Commodity Chemicals

Market Closed - Euronext Amsterdam Other stock markets 11:35:37 2025-06-20 am EDT			5-day change	1st Jan Change
57.62 ^EUR	+1.80%		-0.79%	-0.59%

Jun. 20	AKZO NOBEL NV : Goldman Sachs maintains a Buy rating	ZD
Jun. 20	AKZO NOBEL NV : Buy rating from JP Morgan	ZD

42fe9dd0.p2i8U38dKoAFi6uXKmL-y7_Xm6lvRROVyzVrqIC9SiU.kiaPGhxzGrRkyszeTw6UrfXutvgqNmmkunwdwvLoPkPhX-0kEitjzjDUnw

Published financial data: AKZO NOBEL N.V.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	8.53B	9.59B	10.85B	10.67B	10.71B
Total Revenues	8.53B	9.59B	10.85B	10.67B	10.71B
Cost of Goods Sold, Total	4.74B	5.73B	6.92B	6.43B	6.37B
Gross Profit	3.78B	3.86B	3.92B	4.23B	4.34B
Selling General & Admin Expenses, Total	2.56B	2.56B	2.94B	2.96B	3.09B
R&D Expenses	238M	230M	258M	270M	296M
Other Operating Expenses	5M	-25M	-	-60M	6M
Other Operating Expenses, Total	2.81B	2.77B	3.2B	3.17B	3.39B
Operating Income	977M	1.09B	726M	1.06B	944M
Interest Expense, Total	-76M	-74M	-106M	-193M	-190M
Interest And Investment Income	14M	12M	36M	69M	61M
Net Interest Expenses	-62M	-62M	-70M	-124M	-129M
Income (Loss) On Equity Invest.	25M	26M	18M	27M	23M
Currency Exchange Gains (Loss)	-21M	-	-85M	-128M	-47M
Other Non Operating Income (Expenses)	-	-18M	13M	-7M	32M
EBT, Excl. Unusual Items	919M	1.04B	602M	830M	823M
Merger & Related Restructuring Charges	-	-	-	-	-
Asset Writedown	-	-	-	-	-
Legal Settlements	-	70M	-	-	-
Other Unusual Items	-	-	-	-46M	15M
EBT, Incl. Unusual Items	919M	1.1B	602M	784M	838M
Income Tax Expense	241M	246M	214M	296M	246M
Earnings From Continuing Operations	678M	859M	388M	488M	592M
Earnings Of Discontinued Operations	-7M	6M	-10M	-5M	-
Net Income to Company	671M	865M	378M	483M	592M
Minority Interest	-41M	-36M	-26M	-41M	-50M
Net Income - (IS)	630M	829M	352M	442M	542M
Net Income to Common Incl Extra Items	630M	829M	352M	442M	542M
Net Income to Common Excl. Extra Items	637M	823M	362M	447M	542M
Per Share Items
Net EPS - Basic	3.29	4.48	2.01	2.59	3.17
Basic EPS - Continuing Operations	3.33	4.45	2.07	2.62	3.17
Basic Weighted Average Shares Outstanding	191M	185M	175M	171M	171M
Net EPS - Diluted	3.28	4.46	2	2.58	3.16
Diluted EPS - Continuing Operations	3.32	4.43	2.06	2.61	3.16
Diluted Weighted Average Shares Outstanding	192M	186M	175M	171M	172M
Normalized Basic EPS	2.79	3.3	2	2.8	2.72
Normalized Diluted EPS	2.78	3.29	2	2.79	2.71
Dividend Per Share	1.95	1.98	1.98	1.98	1.98
Payout Ratio	58.1	43.91	107.67	83.26	62.36
American Depositary Receipts Ratio (ADR)	0.33	0.33	0.33	0.33	0.33
Supplemental Items
EBITDA	1.24B	1.35B	996M	1.32B	1.22B
EBITA	1.04B	1.16B	813M	1.14B	1.02B
EBIT	977M	1.09B	726M	1.06B	944M
EBITDAR	1.25B	1.36B	1.01B	1.34B	1.24B
Effective Tax Rate - (Ratio)	26.22	22.26	35.55	37.76	29.36
Total Current Taxes	133M	169M	222M	305M	197M
Total Deferred Taxes	108M	77M	-8M	-9M	49M
Normalized Net Income	533M	611M	350M	478M	464M
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	6M	6M	6M	7M	9M
Non-Cash Pension Expense	-9M	-35M	-18M	-32M	-26M
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.92B	1.99B	2.31B	2.35B	2.46B
General and Administrative Expenses	663M	582M	649M	648M	655M
Research And Development Expense From Footnotes	238M	230M	258M	270M	296M
Net Rental Expense, Total	7M	14M	17M	21M	21M
Imputed Operating Lease Interest Expense	1.67M	2.57M	3.06M	5.67M	5.84M
Imputed Operating Lease Depreciation	5.33M	11.43M	13.94M	15.33M	15.16M
Stock-Based Comp., Other (Total)	14M	18M	16M	18M	23M
Total Stock-Based Compensation	14M	18M	16M	18M	23M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.61B	1.15B	1.45B	1.51B	1.3B
Short Term Investments	250M	58M	336M	265M	165M
Total Cash And Short Term Investments	1.86B	1.21B	1.79B	1.78B	1.47B
Accounts Receivable, Total	1.75B	1.98B	2.12B	2.19B	2.14B
Other Receivables	258M	454M	416M	377M	446M
Total Receivables	2.01B	2.44B	2.54B	2.56B	2.59B
Inventory	1.16B	1.65B	1.84B	1.65B	1.72B
Prepaid Expenses	30M	37M	58M	39M	42M
Other Current Assets, Total	10M	15M	18M	14M	16M
Total Current Assets	5.06B	5.35B	6.24B	6.04B	5.84B
Gross Property Plant And Equipment	5.02B	5.44B	5.75B	5.83B	6.11B
Accumulated Depreciation	-3.07B	-3.34B	-3.49B	-3.54B	-3.67B
Net Property Plant And Equipment	1.94B	2.1B	2.26B	2.3B	2.44B
Long-term Investments	166M	178M	193M	216M	228M
Goodwill	1.1B	1.16B	1.38B	1.43B	1.44B
Other Intangibles, Total	2.46B	2.54B	2.7B	2.65B	2.61B
Loans Receivable Long-Term	87M	88M	89M	89M	91M
Deferred Tax Assets Long-Term	497M	482M	498M	512M	422M
Other Long-Term Assets, Total	1.86B	1.99B	1.39B	1.32B	1.18B
Total Assets	13.18B	13.88B	14.74B	14.56B	14.25B
Liabilities
Accounts Payable, Total	2.03B	2.38B	2.21B	2.31B	2.22B
Accrued Expenses, Total	566M	540M	516M	598M	507M
Short-term Borrowings	28M	715M	2.46B	1.64B	1.52B
Current Portion of Long-Term Debt	5M	754M	2M	671M	87M
Current Portion of Leases	86M	87M	86M	89M	91M
Current Income Taxes Payable	162M	216M	236M	211M	120M
Other Current Liabilities	214M	181M	245M	187M	186M
Total Current Liabilities	3.09B	4.87B	5.75B	5.71B	4.73B
Long-Term Debt	2.53B	1.78B	3.13B	2.97B	3.47B
Long-Term Leases	238M	212M	198M	194M	201M
Pension & Other Post Retirement Benefits	664M	578M	387M	423M	381M
Deferred Tax Liability Non Current	467M	567M	561M	557M	491M
Other Non Current Liabilities	232M	234M	167M	161M	160M
Total Liabilities	7.23B	8.24B	10.19B	10.01B	9.43B
Common Stock, Total	95M	91M	87M	85M	85M
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	794M	5.85B	4.94B	679M	786M
Comprehensive Income and Other	4.86B	-512M	-693M	3.56B	3.7B
Total Common Equity	5.75B	5.42B	4.33B	4.32B	4.57B
Minority Interest	204M	211M	215M	224M	242M
Total Equity	5.95B	5.64B	4.55B	4.55B	4.82B
Total Liabilities And Equity	13.18B	13.88B	14.74B	14.56B	14.25B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	190M	179M	170M	171M	171M
ECS Total Common Shares Outstanding	190M	179M	170M	171M	171M
Book Value / Share	30.26	30.33	25.42	25.33	26.78
Tangible Book Value	2.19B	1.74B	261M	241M	525M
Tangible Book Value Per Share	11.54	9.7	1.53	1.41	3.07
Total Debt	2.89B	3.55B	5.88B	5.56B	5.37B
Net Debt	1.03B	2.34B	4.09B	3.78B	3.9B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-966M	-1.15B	-718M	-659M	-616M
Debt Equivalent Oper. Leases	56M	112M	136M	168M	168M
Minority Interest, Total (Incl. Fin. Div)	204M	211M	215M	224M	242M
Equity Method Investments, Total	166M	178M	193M	216M	228M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	378M	611M	676M	579M	601M
Inventories - Work In Process, Total	70M	94M	104M	91M	101M
Inventories - Finished Goods, Total	711M	945M	1.06B	979M	1.02B
Land - (BS)	-	-	-	-	1.74B
Buildings, Total	1.42B	1.55B	1.66B	1.66B	-
Machinery, Total	2.83B	3.04B	3.13B	3.21B	3.37B
Full Time Employees	32.2K	32.8K	35.2K	33.96K	33.75K
Part Time Employees	-	-	-	1.61K	1.58K
Accumulated Allowance for Doubtful Accounts (Supple)	58M	42M	42M	39M	34M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	630M	829M	352M	442M	542M
Depreciation & Amortization - CF	297M	281M	281M	277M	293M
Amortization of Goodwill and Intangible Assets - (CF)	64M	70M	87M	80M	78M
Depreciation & Amortization, Total	361M	351M	368M	357M	371M
(Gain) Loss From Sale Of Asset	-	-	-	-	-
Asset Writedown & Restructuring Costs	10M	3M	6M	4M	-
(Income) Loss On Equity Investments - (CF)	-25M	-26M	-18M	-27M	-23M
Net Cash From Discontinued Operations	-3M	-1M	-9M	-6M	-5M
Other Operating Activities, Total	128M	2M	128M	149M	-18M
Change In Accounts Receivable	-14M	-240M	-95M	-111M	12M
Change In Inventories	-84M	-439M	-134M	131M	-83M
Change In Accounts Payable	282M	274M	-280M	234M	-135M
Change in Other Net Operating Assets	-68M	-149M	-64M	-53M	7M
Cash from Operations	1.22B	604M	254M	1.12B	668M
Capital Expenditure	-258M	-288M	-292M	-286M	-306M
Cash Acquisitions	-113M	-73M	-588M	-114M	2M
Divestitures	31M	22M	36M	96M	1M
Investment in Marketable and Equity Securities, Total	-112M	191M	-277M	78M	103M
Other Investing Activities, Total	25M	14M	26M	82M	68M
Cash from Investing	-427M	-134M	-1.1B	-144M	-132M
Long-Term Debt Issued, Total	970M	1.14B	9.51B	5.84B	2.81B
Total Debt Issued	970M	1.14B	9.51B	5.84B	2.81B
Long-Term Debt Repaid, Total	-339M	-590M	-7.32B	-6.3B	-3.1B
Total Debt Repaid	-339M	-590M	-7.32B	-6.3B	-3.1B
Repurchase of Common Stock	-555M	-1.14B	-669M	-	-
Common Dividends Paid	-366M	-364M	-379M	-368M	-338M
Common & Preferred Stock Dividends Paid	-366M	-364M	-379M	-368M	-338M
Special Dividend Paid	-	-	-	-	-
Other Financing Activities, Total	-63M	-28M	-	-	-51M
Cash from Financing	-353M	-974M	1.14B	-827M	-684M
Foreign Exchange Rate Adjustments	-66M	35M	-14M	-94M	-32M
Net Change in Cash	371M	-469M	286M	55M	-180M
Supplemental Items
Cash Interest Paid	47M	77M	78M	167M	174M
Cash Income Tax Paid (Refund)	165M	222M	224M	295M	291M
Levered Free Cash Flow	948M	124M	49.5M	929M	181M
Unlevered Free Cash Flow	996M	171M	116M	1.05B	300M
Change In Net Working Capital	-268M	591M	430M	-297M	378M
Net Debt Issued / Repaid	631M	553M	2.19B	-459M	-295M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	4.67	5.03	3.17	4.53	4.1
Return on Total Capital	6.93	7.55	4.63	6.47	5.81
Return On Equity %	10.83	14.83	7.62	10.73	12.65
Return on Common Equity	10.53	14.73	7.42	10.33	12.19
Margin Analysis
Gross Profit Margin %	44.37	40.21	36.17	39.69	40.49
SG&A Margin	30.07	26.71	27.1	27.77	28.86
EBITDA Margin %	14.53	14.04	9.18	12.37	11.34
EBITA Margin %	12.2	12.09	7.5	10.7	9.54
EBIT Margin %	11.45	11.36	6.69	9.96	8.81
Income From Continuing Operations Margin %	7.95	8.96	3.58	4.57	5.53
Net Income Margin %	7.39	8.65	3.25	4.14	5.06
Net Avail. For Common Margin %	7.47	8.58	3.34	4.19	5.06
Normalized Net Income Margin	6.25	6.37	3.23	4.48	4.34
Levered Free Cash Flow Margin	11.12	1.3	0.46	8.71	1.69
Unlevered Free Cash Flow Margin	11.67	1.78	1.07	9.84	2.8
Asset Turnover
Asset Turnover	0.65	0.71	0.76	0.73	0.74
Fixed Assets Turnover	4.24	4.74	4.97	4.68	4.52
Receivables Turnover (Average Receivables)	4.79	5.14	5.3	4.95	4.95
Inventory Turnover (Average Inventory)	4.13	4.08	3.96	3.68	3.78
Short Term Liquidity
Current Ratio	1.64	1.1	1.09	1.06	1.23
Quick Ratio	1.25	0.75	0.75	0.76	0.86
Operating Cash Flow to Current Liabilities	0.39	0.12	0.04	0.2	0.14
Days Sales Outstanding (Average Receivables)	76.44	71.06	68.92	73.73	74
Days Outstanding Inventory (Average Inventory)	88.63	89.43	92.08	99.05	96.75
Average Days Payable Outstanding	150.36	129.27	117.51	132.14	128.66
Cash Conversion Cycle (Average Days)	14.71	31.22	43.49	40.64	42.09
Long Term Solvency
Total Debt/Equity	48.57	62.99	129.18	122.37	111.46
Total Debt / Total Capital	32.69	38.65	56.37	55.03	52.71
LT Debt/Equity	46.57	35.38	73.26	69.62	76.22
Long-Term Debt / Total Capital	31.35	21.71	31.97	31.31	36.05
Total Liabilities / Total Assets	54.85	59.39	69.15	68.77	66.2
EBIT / Interest Expense	12.86	14.72	6.85	5.5	4.97
EBITDA / Interest Expense	17.61	19.46	10.32	7.35	6.92
(EBITDA - Capex) / Interest Expense	14.21	15.57	7.57	5.87	5.31
Total Debt / EBITDA	2.16	2.47	5.37	3.92	4.08
Net Debt / EBITDA	0.77	1.62	3.74	2.67	2.97
Total Debt / (EBITDA - Capex)	2.68	3.08	7.33	4.91	5.32
Net Debt / (EBITDA - Capex)	0.96	2.03	5.1	3.34	3.87
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-8.04	12.39	13.13	-1.64	0.4
Gross Profit, 1 Yr. Growth %	-4.47	1.85	0.49	7.93	2.43
EBITDA, 1 Yr. Growth %	10.92	9.88	-26	32.53	-7.95
EBITA, 1 Yr. Growth %	12.06	12.85	-29.85	40.47	-10.51
EBIT, 1 Yr. Growth %	13.34	13.08	-33.33	46.28	-11.11
Earnings From Cont. Operations, 1 Yr. Growth %	22.16	26.7	-54.83	25.77	21.31
Net Income, 1 Yr. Growth %	16.88	31.59	-57.54	25.57	22.62
Normalized Net Income, 1 Yr. Growth %	17.84	14.53	-42.66	31.7	-2.8
Diluted EPS Before Extra, 1 Yr. Growth %	37.19	33.43	-53.5	26.7	21.07
Accounts Receivable, 1 Yr. Growth %	-3.37	13.19	7.6	3.01	-1.97
Inventory, 1 Yr. Growth %	1.76	42.36	11.7	-10.53	4.37
Net Property, Plant and Equip., 1 Yr. Growth %	-6.22	8.17	7.37	1.64	6.27
Total Assets, 1 Yr. Growth %	1.49	5.32	6.22	-1.24	-2.12
Tangible Book Value, 1 Yr. Growth %	-19.56	-20.85	-84.96	-7.66	117.84
Common Equity, 1 Yr. Growth %	-9.51	-5.59	-20.13	-0.25	5.83
Cash From Operations, 1 Yr. Growth %	5.19K	-50.37	-57.95	340.94	-40.36
Capital Expenditures, 1 Yr. Growth %	20.56	11.63	1.39	-2.05	6.99
Levered Free Cash Flow, 1 Yr. Growth %	128.19	-86.88	-60.2	1.78K	-80.49
Unlevered Free Cash Flow, 1 Yr. Growth %	111.05	-82.71	-32.16	806.91	-71.42
Dividend Per Share, 1 Yr. Growth %	2.63	1.54	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-4	1.66	12.76	5.49	-0.62
Gross Profit, 2 Yr. CAGR %	-1.82	-1.36	1.81	4.14	5.14
EBITDA, 2 Yr. CAGR %	20.45	9.77	-9.83	-0.97	10.45
EBITA, 2 Yr. CAGR %	24.37	11.7	-11.03	-0.74	12.12
EBIT, 2 Yr. CAGR %	26.04	12.4	-13.17	-1.25	14.03
Earnings From Cont. Operations, 2 Yr. CAGR %	22.07	24.41	-24.35	-24.63	23.52
Net Income, 2 Yr. CAGR %	-69.28	24.02	-25.25	-26.98	24.09
Normalized Net Income, 2 Yr. CAGR %	35.04	16.17	-18.96	-11.57	13.14
Diluted EPS Before Extra, 2 Yr. CAGR %	37.57	35.3	-21.23	-23.24	23.85
Accounts Receivable, 2 Yr. CAGR %	-2.53	4.59	10.11	5.28	0.49
Inventory, 2 Yr. CAGR %	0.87	20.36	26.1	-0.03	-3.37
Net Property, Plant and Equip., 2 Yr. CAGR %	5.48	0.72	7.77	4.46	3.93
Total Assets, 2 Yr. CAGR %	-16.24	3.39	5.77	2.42	-1.68
Tangible Book Value, 2 Yr. CAGR %	-48.84	-20.21	-65.49	-62.73	41.83
Common Equity, 2 Yr. CAGR %	-30.32	-7.57	-13.16	-10.74	2.74
Cash From Operations, 2 Yr. CAGR %	54.02	412.45	-54.32	36.17	62.17
Capital Expenditures, 2 Yr. CAGR %	18.41	16.01	6.39	-0.35	2.37
Levered Free Cash Flow, 2 Yr. CAGR %	-38.39	-45.29	-77.15	173.32	91.35
Unlevered Free Cash Flow, 2 Yr. CAGR %	-37.6	-39.86	-65.75	148.04	60.99
Dividend Per Share, 2 Yr. CAGR %	2.77	2.08	0.77	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-3.9	1.18	5.35	7.74	3.76
Gross Profit, 3 Yr. CAGR %	-3.67	-0.61	-0.33	3.81	3.57
EBITDA, 3 Yr. CAGR %	4.24	16.38	-3.75	2.52	-3.36
EBITA, 3 Yr. CAGR %	8.37	19.86	-4.35	3.6	-4.11
EBIT, 3 Yr. CAGR %	6.1	20.98	-5.56	3.32	-4.65
Earnings From Cont. Operations, 3 Yr. CAGR %	9.88	23.59	-11.25	-10.38	-11.67
Net Income, 3 Yr. CAGR %	-8.85	-50.11	-13.24	-11.14	-13.21
Normalized Net Income, 3 Yr. CAGR %	9.57	27.82	-8.19	-3.6	-8.73
Diluted EPS Before Extra, 3 Yr. CAGR %	19.29	36.18	-5.23	-7.71	-10.65
Accounts Receivable, 3 Yr. CAGR %	0.99	2.45	5.42	7.69	2.81
Inventory, 3 Yr. CAGR %	1.94	13.15	17.4	12.47	1.41
Net Property, Plant and Equip., 3 Yr. CAGR %	2.02	6.37	2.89	5.69	5.06
Total Assets, 3 Yr. CAGR %	-6.61	-9.6	4.32	3.38	0.88
Tangible Book Value, 3 Yr. CAGR %	-3.72	-40.83	-54.25	-52.09	-32.86
Common Equity, 3 Yr. CAGR %	-0.68	-22.89	-11.96	-9.06	-5.53
Cash From Operations, 3 Yr. CAGR %	7.89	5.59	122.69	-2.73	3.41
Capital Expenditures, 3 Yr. CAGR %	1.06	16.11	10.91	3.49	2.04
Levered Free Cash Flow, 3 Yr. CAGR %	-16.47	-63.21	-50.79	-0.67	13.37
Unlevered Free Cash Flow, 3 Yr. CAGR %	-13.92	-59.44	-37.4	2.08	20.7
Dividend Per Share, 3 Yr. CAGR %	-11.49	2.36	1.38	0.51	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-10.51	0.32	2.45	2.88	2.92
Gross Profit, 5 Yr. CAGR %	-9.03	-2.32	-1.51	1.52	1.83
EBITDA, 5 Yr. CAGR %	-10.31	2.14	-1.86	9.1	1.7
EBITA, 5 Yr. CAGR %	-8.78	2.89	-0.12	11.16	1.93
EBIT, 5 Yr. CAGR %	-8.33	3.23	-2.36	11.54	1.83
Earnings From Cont. Operations, 5 Yr. CAGR %	-8.55	6.88	-5.36	1.41	1.3
Net Income, 5 Yr. CAGR %	-8.44	-3.09	-15.81	-41.9	0.11
Normalized Net Income, 5 Yr. CAGR %	-7.87	6.34	-2.89	10.31	0.51
Diluted EPS Before Extra, 5 Yr. CAGR %	-5.42	13.19	1.04	8.27	5.48
Accounts Receivable, 5 Yr. CAGR %	-5.03	-2.69	4.54	3.48	3.42
Inventory, 5 Yr. CAGR %	-5.08	1.5	10.99	7.68	8.61
Net Property, Plant and Equip., 5 Yr. CAGR %	-13.44	-12.87	4.28	5.61	3.3
Total Assets, 5 Yr. CAGR %	-3.76	-3.04	-1.84	-4.97	1.88
Tangible Book Value, 5 Yr. CAGR %	-1.2	-4.11	-36.13	-50.82	-28.06
Common Equity, 5 Yr. CAGR %	-2.39	-3.71	-5.88	-18.25	-6.35
Cash From Operations, 5 Yr. CAGR %	1.49	-14.09	-23.49	16.9	96.16
Capital Expenditures, 5 Yr. CAGR %	-16.9	-14.6	3.15	9.22	7.41
Levered Free Cash Flow, 5 Yr. CAGR %	-1.42	15.03	-50.27	-17.95	-15.29
Unlevered Free Cash Flow, 5 Yr. CAGR %	-2.1	4.24	-40.57	-16.31	-8.66
Dividend Per Share, 5 Yr. CAGR %	2.26	1.3	-6.78	1.41	0.83